| Abstract: |
The mechanisms that regulate protein synthesis in hematopoietic stem and progenitor cells (HSPCs) are poorly understood. Spevak, Elias, and colleagues provide a comprehensive characterization of the translatome in mouse HSPCs and show that mTOR- and CDK1-dependent mechanisms activate translation during distinct steps in hematopoietic development. © 2019 Elsevier Inc. Hematopoietic stem cells (HSCs) require highly regulated rates of protein synthesis, but it is unclear if they or lineage-committed progenitors preferentially recruit transcripts to translating ribosomes. We utilized polysome profiling, RNA sequencing, and whole-proteomic approaches to examine the translatome in LSK (Lin−Sca-1+c-Kit+) and myeloid progenitor (MP; Lin−Sca-1−c-Kit+) cells. Our studies show that LSKs exhibit low global translation but high translational efficiencies (TEs) of mRNAs required for HSC maintenance. In contrast, MPs activate translation in an mTOR-independent manner due, at least in part, to proteasomal degradation of mTOR by the E3 ubiquitin ligase c-Cbl. In the near absence of mTOR, CDK1 activates eIF4E-dependent translation in MPs through phosphorylation of 4E-BP1. Aberrant activation of mTOR expression and signaling in c-Cbl-deficient MPs results in increased mature myeloid lineage output. Overall, our data demonstrate that hematopoietic stem and progenitor cells (HSPCs) undergo translational reprogramming mediated by previously uncharacterized mechanisms of translational regulation. © 2019 Elsevier Inc. |
